Pan Asian Microvent(688386)

Search documents
泛亚微透:泛亚微透关于召开2023年第三季度业绩说明会的公告
2023-11-14 08:04
证券代码:688386 证券简称:泛亚微透 公告编号:2023- 045 江苏泛亚微透科技股份有限公司 关于召开 2023 年第三季度业绩说明会的公告 重要内容提示: https://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2023 年 11 月 15 日(星期三) 至 11 月 21 日(星期二)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zhengquan@microvent.com.cn 进行提问。公司将在说明会上对投资者普遍关注 的问题进行回答。 江苏泛亚微透科技股份有限公司(以下简称"公司")已于 2023 年 10 月 28 日发布公司 2023 年第三季度报告,为便于广大投资者更全面深入地了解公司 2023 年第三季度经营成果、财务状况,公司计划于 2023 年 11 月 22 日下午 13:00-14:00 举行 2023 年第三季度业绩说明会,就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开,公司将针对 2023 年第三季度的经 营成果及财务指标的具体情况与投资者进行互动交 ...
泛亚微透(688386) - 2023 Q3 - 季度财报
2023-10-27 16:00
Financial Performance - The company's operating revenue for Q3 2023 was ¥112,673,360.34, representing a year-over-year increase of 13.46%[3] - The net profit attributable to shareholders for the same period was ¥18,809,807.50, up 14.88% compared to the previous year[3] - The basic earnings per share for Q3 2023 was ¥0.27, reflecting a 17.39% increase year-over-year[3] - The company reported a net profit growth of 37.46% for the year-to-date, attributed to stable growth in core business areas[7] - Total operating revenue for the first three quarters of 2023 reached CNY 288,588,445.42, an increase of 17.5% compared to CNY 245,570,860.75 in the same period of 2022[19] - Operating profit for the first three quarters of 2023 was CNY 73,585,438.09, up 53.2% from CNY 48,034,799.66 in the first three quarters of 2022[19] - Net profit for Q3 2023 was CNY 63,708,705.72, representing a 50.1% increase from CNY 42,431,872.47 in Q3 2022[20] - Basic earnings per share for Q3 2023 were CNY 0.84, compared to CNY 0.61 in Q3 2022, reflecting a 37.7% increase[20] - The company reported a total profit of CNY 73,377,803.20 for the first three quarters of 2023, an increase of 52.8% compared to CNY 48,034,050.60 in the same period of 2022[19] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥49,694,277.18, showing a decline of 13.55% year-over-year[3] - Cash flow from operating activities for the first three quarters of 2023 was CNY 49,694,277.18, down 13.1% from CNY 57,484,160.80 in the same period of 2022[24] - Cash flow from investing activities showed a net outflow of CNY 41,384,469.97 in the first three quarters of 2023, compared to a net outflow of CNY 149,257,125.45 in the same period of 2022[25] - Cash and cash equivalents decreased to RMB 67,270,586.17 from RMB 106,229,233.62, a decline of about 36.7%[13] - Cash and cash equivalents at the end of Q3 2023 were CNY 67,270,586.17, down from CNY 76,480,102.70 at the end of Q3 2022[25] Research and Development - Research and development expenses totaled ¥5,024,675.87, accounting for 4.46% of operating revenue, a decrease of 0.03 percentage points from the previous year[4] - Research and development expenses for the first three quarters of 2023 were CNY 15,359,579.82, up 26.5% from CNY 12,182,632.42 in the same period of 2022[19] Assets and Liabilities - The total assets of the company at the end of the reporting period were ¥900,579,759.33, a slight increase of 0.99% from the end of the previous year[4] - As of September 30, 2023, the company's total assets amounted to RMB 900,579,759.33, an increase from RMB 891,727,828.65 at the end of 2022, reflecting a growth of approximately 1.0%[14] - The company's current assets totaled RMB 375,855,026.63, slightly down from RMB 379,454,266.08 at the end of 2022, indicating a decrease of about 0.8%[13] - Non-current assets increased to RMB 524,724,732.70 from RMB 512,273,562.57, representing a growth of approximately 2.8%[14] - The company's total liabilities decreased to RMB 224,628,063.07 from RMB 244,484,838.11, a reduction of about 8.1%[15] - The equity attributable to shareholders rose to RMB 641,377,844.75 from RMB 617,543,284.47, marking an increase of approximately 3.9%[15] - The company reported a decrease in short-term borrowings to RMB 49,043,100.00 from RMB 49,552,916.67, a decline of approximately 1.0%[15] - The company’s long-term investments increased to RMB 137,434,272.18 from RMB 99,798,720.98, representing a growth of approximately 37.7%[14] Inventory and Receivables - Accounts receivable decreased to RMB 140,865,947.60 from RMB 147,455,483.31, reflecting a decrease of approximately 4.5%[13] - Inventory increased to RMB 91,750,903.17 from RMB 77,423,153.84, indicating a growth of about 18.5%[13]
泛亚微透:东方证券承销保荐有限公司关于江苏泛亚微透科技股份有限公司首次公开发行部分限售股上市流通的核查意见
2023-10-09 09:14
关于江苏泛亚微透科技股份有限公司 首次公开发行部分限售股上市流通的核查意见 东方证券承销保荐有限公司(以下简称"东方投行""保荐机构")作为江苏 泛亚微透科技股份有限公司(以下简称"泛亚微透""公司")首次公开发行股票 并在科创板上市持续督导保荐机构,根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管 指引第 1 号——规范运作》及《上海证券交易所上市公司自律监管指引第 11 号 ——持续督导》等有关规定,对公司首次公开发行部分限售股上市流通的事项进 行了审慎核查,具体情况如下: 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2020 年 9 月 1 日出具的《关于同意江苏泛 亚微透科技股份有限公司首次公开发行股票注册的批复》(证监许可[2020]2015 号),泛亚微透首次向社会公开发行人民币普通股(A 股)17,500,000 股,并于 2020 年 10 月 16 日在上海证券交易所科创板挂牌上市。公司首次公开发行股票 完成后,总股本为 70,000,000 股,其中有限售条件流通股 55,751,860 股,无限 售条件流通股 ...
泛亚微透:泛亚微透关于首次公开发行部分限售股上市流通公告
2023-10-09 09:14
重要内容提示: 关于首次公开发行部分限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 本次上市流通的限售股数量为 22,638,512 股,占总股本比例为 32.34%, 限售期为自公司首次公开发行的股票在上海证券交易所科创板上市之日起 36 个 月。 本次上市流通日期为 2023 年 10 月 16 日。 证券代码:688386 证券简称:泛亚微透 公告编号:2023-043 江苏泛亚微透科技股份有限公司 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2020 年 9 月 1 日出具的《关于同意江苏泛 亚微透科技股份有限公司首次公开发行股票注册的批复》(证监许可[2020]2015 号),江苏泛亚微透科技股份有限公司(以下简称:"泛亚微透"或 "公司") 首次向社会公开泛亚微透民币普通股(A 股)17,500,000 股,并于 2020 年 10 月 16 日在上海证券交易所科创板挂牌上市。公司首次公开发行股票完成后,总股 本为 70,000,000 股,其中有限售条件流通股 55,751 ...
泛亚微透:泛亚微透关于获得发明专利的自愿性披露公告
2023-10-09 08:16
证券代码:688386 证券简称:泛亚微透 公告编号:2023-044 江苏泛亚微透科技股份有限公司 关于获得发明专利的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真性、准确性和完整性承担个别及连带责任。 江苏泛亚微透科技股份有限公司(以下简称"公司"或"泛亚微透")于近 日收到了 1 项国家知识产权局颁发的授权发明专利证书,具体如下: 江苏泛亚微透科技股份有限公司 董事会 2023 年 10 月 10 日 发明专利名 称 专利号 专利申请日 授权公告日 专利权人 专利期限 一种航空航 天用高性能 聚酰亚胺/含 氟聚合物绝 缘复合薄 膜、制备方 法及其应用 ZL202110718576.1 2021.06.28 2023.09.26 泛亚微透 20 年(自 申 请 日 起 算) 一、专利证书的基本情况 二、对公司的影响 上述发明专利的取得是公司重要核心技术的体现和延伸,本次专利的获得不 会对公司近期经营产生重大影响,但有利于进一步完善公司知识产权保护体系, 发挥自主知识产权的技术优势,促进技术创新,从而提升公司核心竞争力。 特此公告。 ...
泛亚微透:泛亚微透关于持股5%以上股东集中竞价减持计划时间届满未减持公司股份的公告
2023-09-07 10:02
证券代码:688386 证券简称:泛亚微透 公告编号:2023-041 江苏泛亚微透科技股份有限公司关于持股 5%以上股东 集中竞价减持计划时间届满未减持公司股份的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示: 股东持股的基本情况 本次减持计划实施前,江苏泛亚微透科技股份有限公司(以下简称"泛亚微 透"或"公司")股东江苏南方精工股份有限公司(以下简称"南方精工")持有 公司 5,583,157 股,占公司总股本比例为 7.98%。上述股份来源于泛亚微透首次 公开发行前持有的股份, 且已于 2021 年 10 月 18 日起上市流通。 集中竞价减持计划的实施结果情况 | 股东名称 | 股东身份 | 持股数量(股) | 持股比例 | | 当前持股股份来源 | | --- | --- | --- | --- | --- | --- | | 江苏南方精工股份 | 5%以上非第一大股东 | 5,583,157 | | 7.98% IPO | 前取得:5,583,157 股 | | 有限公司 | | ...
泛亚微透:泛亚微透关于召开2023年半年度业绩说明会的公告
2023-09-07 10:02
投资者可于 2023 年 09 月 13 日(星期三) 至 09 月 19 日(星期二)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zhengquan@microvent.com.cn 进行提问。公司将在说明会上对投资者普遍关注 的问题进行回答。 证券代码:688386 证券简称:泛亚微透 公告编号:2023-042 江苏泛亚微透科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 会议召开时间:2023 年 09 月 20 日(星期三) 下午 13:00-14:00 会议召开地点:上海证券交易所上证路演中心(网址: https://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 三、 参加人员 (三) 会议召开方式:上证路演中心网络互动 江苏泛亚微透科技股份有限公司(以下简称"公司")已于 2023 年 8 月 29 日发布公司 2023 年半年度报告,为便于广大投资者更全面深入地了解 ...
泛亚微透:东方证券承销保荐有限公司关于江苏泛亚微透科技股份有限公司2023年半年度持续督导跟踪报告
2023-08-31 08:12
东方证券承销保荐有限公司 关于江苏泛亚微透科技股份有限公司 公司产品主要应用于汽车、消费电子等领域,近几年,由于地缘政治、国际 贸易战等原因,全球的宏观经济形势仍然存在一定的不确定性。如果宏观经济环 境发生重大不利变化、经济步入下行周期或影响下游终端消费电子、汽车行业的 市场需求因素发生显著变化,则可能对公司经营业绩造成不利影响。 (二)经营风险 2023 年半年度持续督导跟踪报告 东方证券承销保荐有限公司(以下简称"东方投行""保荐机构")作为江苏 泛亚微透科技股份有限公司(以下简称"泛亚微透""公司")首次公开发行股票 并在科创板上市的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证 券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第 11 号 ——持续督导》等有关法律法规和规范性文件的要求,负责泛亚微透上市后的持 续督导工作,并本出具持续督导跟踪报告。 一、持续督导工作情况 | 序 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 号 | | | | 1 | 建立健全并有效执行持续督导工作制度, | 保荐机构已制定持续督导计划,并依 | | | 并针对 ...
泛亚微透(688386) - 2023 Q2 - 季度财报
2023-08-28 16:00
Financial Performance - The company's operating revenue for the first half of 2023 was RMB 175,915,085.08, representing a 20.27% increase compared to RMB 146,264,226.11 in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2023 was RMB 40,024,752.78, a 51.44% increase from RMB 26,429,385.92 year-on-year[19]. - The basic earnings per share for the first half of 2023 was RMB 0.57, up 50.00% from RMB 0.38 in the same period last year[20]. - The company reported a non-recurring profit of 12,697,611.19, after accounting for tax effects and minority interests[24]. - The company achieved operating revenue of 175.92 million yuan, a year-on-year increase of 20.27%[74]. - The net profit attributable to shareholders reached 40.02 million yuan, reflecting a year-on-year growth of 51.44%[74]. Cash Flow and Assets - The net cash flow from operating activities decreased by 59.92% to RMB 22,188,844.73, down from RMB 55,358,250.49 in the previous year, primarily due to increased material procurement and tax payments[21]. - The company's total assets decreased by 1.78% to RMB 875,877,476.07 compared to RMB 891,727,828.65 at the end of the previous year[20]. - The company's cash and cash equivalents decreased to RMB 54,006,145.52 from RMB 106,229,233.62, a decline of about 49.1%[168]. - The company's total liabilities decreased to RMB 219,860,117.97 from RMB 244,484,838.11, a decline of approximately 10.0%[170]. - The company's equity increased to RMB 656,017,358.10 from RMB 647,242,990.54, representing a growth of about 1.2%[170]. Research and Development - Research and development expenses accounted for 5.87% of operating revenue, an increase of 0.59 percentage points from the previous year[20]. - The company achieved a total R&D expenditure of ¥10,334,903.95, representing a 33.73% increase compared to ¥7,728,290.53 in the same period last year[52]. - The number of R&D personnel increased to 72, representing 20.06% of the total workforce, compared to 56 personnel and 16.57% in the same period last year[66]. - The average salary of R&D personnel decreased to 7.13 million RMB from 8.22 million RMB in the previous year[66]. - The company has established a complete technology system for ePTFE membranes and composite materials, covering production, modification, and application processes[67]. Product Development and Innovation - The company specializes in the research, production, and sales of ePTFE membranes and SiO2 aerogels, targeting high-performance composite materials[28]. - The CMD solution has been adopted by 31 automotive lighting manufacturers and 16 OEMs, significantly reducing manufacturing processes and costs associated with fog solutions[39]. - The company has developed high-performance desiccants with a moisture absorption capacity of up to 200% of their own weight, which can be reversibly dried and used for extended periods[46]. - The company has developed a novel silica aerogel material for sound insulation and thermal insulation, achieving a sample verification with a major engineering project, enhancing comfort and health for personnel[59]. - The company has initiated multiple new R&D projects to develop new products and expand market space, leading to increased material consumption and testing costs[54]. Market and Strategic Focus - The company is focusing on expanding into new niche markets, particularly in the automotive sector, to meet the demands of the "new four modernizations"[76]. - The company aims to enhance its product offerings in the aviation sector with new sealing materials, which are expected to improve safety and reliability[57]. - The company is actively pursuing high-performance membrane materials for applications in cables and cable components, aligning with its development strategy of product diversification and market niche[106]. - The company has outlined a strategic plan for mergers and acquisitions, aiming to complete at least two acquisitions by the end of the fiscal year[130]. - The company is focusing on market expansion, targeting a 15% increase in market share over the next fiscal year[130]. Risk Management - The company has outlined various risks and countermeasures in its report, emphasizing the importance of risk management in its operations[4]. - The company is facing risks related to macroeconomic uncertainties and potential goodwill impairment from previous acquisitions[81][82]. - The company faces risks related to high customer concentration in the automotive industry, which could impact demand if customer operations decline[86]. - The company has implemented policies to prevent core technology leakage and personnel loss, which are critical for maintaining competitive advantage[85]. Environmental Responsibility - The company has established an emergency response plan for environmental incidents, which has been filed with the relevant environmental authority[119]. - The company conducts quarterly third-party monitoring of its wastewater, waste gas, and noise emissions, ensuring compliance with environmental standards[120]. - The company has implemented measures to reduce VOCs and particulate matter emissions through upgrades to its production facilities[122]. - The company promotes waste classification and recycling among employees, contributing to environmental awareness[124]. - The company is engaged in research and development of new products that contribute to carbon reduction and practices green office initiatives[126]. Shareholder and Governance - The company has committed to maintaining transparency in its financial reporting and adhering to regulatory requirements[133]. - The company has committed to repurchase shares if there are significant misstatements or omissions in the prospectus, with the commitment period starting from March 26, 2020, and lasting indefinitely[128]. - The company will not transfer or delegate the management of its shares within 36 months from the date of stock issuance[136]. - The company has not reported any changes in controlling shareholders or actual controllers during the reporting period[164]. - The company has not reported any significant changes in shareholding or shareholder structure during the reporting period[157].
泛亚微透:泛亚微透关于2023年半年度募集资金存放与实际使用情况的专项报告
2023-08-28 10:31
证券代码:688386 证券简称:泛亚微透 公告编号:2023-040 江苏泛亚微透科技股份有限公司 关于2023年半年度募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真性、准确性和完整性承担个别及连带责任。 一、募集资金基本情况 (一)募集资金金额和资金到账时间 根据中国证券监督管理委员会于 2020 年 9 月 1 日出具的《关于同意江苏泛 亚微透科技股份有限公司首次公开发行股票注册的批复》(证监许可〔2020〕2015 号)核准,江苏泛亚微透科技股份有限公司(以下简称"公司")获准首次向社 会公众公开发行人民币普通股 17,500,000 股,每股面值为人民币 1.00 元,发 行价格为每股人民币 16.28 元/股,募集资金总额为人民币 284,900,000 元,扣 除发行费用人民币 47,369,737.04 元后,公司本次募集资金净额为人民币 237,530,262.96 元。截至 2020 年 10 月 13 日,上述募集资金已经全部到位。 以上募集资金的到位情况已由天健会计师事务所(特殊普通合伙)审验并于 ...